Median Technologies to Participate in the Cowen’s 42nd Annual Health Care Conference
01 Mars 2022 - 05:45PM
Business Wire
Regulatory News:
Median Technologies (Paris: ALMDT), will be participating in the
Cowen’s 42nd Annual Health Care Conference, taking place virtually
on March 7-9, 2022.
Fredrik Brag, Median’s CEO and founder will present on March 7th
at 9:10 am ET (3:10 pm CET).
The live presentation will be available here and the replay will
be posted on the Investors section of the Median Technologies
website.
Cowen’s 42nd Annual Health Care Conference incorporates
presentations, fireside chats and innovative panel discussions
hosted by members of the Cowen research team that focus on various
aspects of the health care industry.
Cowen Inc. (“Cowen” or the “Company”) is a diversified financial
services firm that operates through two business segments: a broker
dealer and an investment management division. The Company’s broker
dealer division offers investment banking services, equity
research, sales and trading, prime brokerage, global clearing and
commission management services. Cowen’s investment management
division builds on Cowen’s core insights by developing
differentiated, actively managed investment strategies that seek to
meet the dynamic needs of our clients. Founded in 1918, the firm is
headquartered in New York and has offices worldwide. Learn more at
Cowen.com.
About Median Technologies: About Median Technologies: Median
Technologies provides innovative imaging solutions and services to
advance healthcare for everyone. We harness the power of medical
images by using the most advanced Artificial Intelligence
technologies, to increase the accuracy of diagnosis and treatment
of many cancers and other metabolic diseases at their earliest
stages and provide insights into novel therapies for patients. Our
iCRO solutions for medical image analysis and management in
oncology trials and iBiopsy®, our AI-powered software as medical
device help biopharmaceutical companies and clinicians to bring new
treatments and diagnose patients earlier and more accurately. This
is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a
subsidiary in the US and another one in Shanghai, Median has
received the label “Innovative company” by the BPI and is listed on
Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median
is eligible for the French SME equity savings plan scheme
(PEA-PME), is part of the Enternext® PEA-PME 150 index and has been
awarded the Euronext European Rising Tech label. For more
information: www.mediantechnologies.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220301005772/en/
Median Technologies Emmanuelle Leygues Head of Corporate
& Marketing Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press - ALIZE RP Caroline Carmagnol +33 6 64 18 99 59
median@alizerp.com
Investors - ACTIFIN Ghislaine Gasparetto +33 6 21 10 49
24 ggasparetto@actifin.fr
Median Technologies (EU:ALMDT)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Median Technologies (EU:ALMDT)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024